title: New developments in lupus-associated antiphospholipid syndrome.
abstract: Systemic lupus erythematosus is the disease in which the antiphospholipid syndrome was first described more than 20 years ago and which is the most frequent underlying disorder in secondary antiphospholipid syndrome. With respect to pathogenic concepts and treatment, the subjects of this review, no clear distinction between primary and secondary antiphospholipid syndrome can be made.
authors.affiliation: The Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery, Weill Medical College of Cornel University, New York, New York, USA.
authors.forename: M D
authors.initials: MD
authors.lastname: Lockshin
authors.forename: R H W M
authors.initials: RH
authors.lastname: Derksen
mesh_terms: D000818:Animals; D016736:Antiphospholipid Syndrome / Q000276:immunology*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D013927:Thrombosis / Q000276:immunology / Q000517:prevention & control